Sterling
Novo Nordisk logo
Novo Nordisk
Amgen logo
Amgen

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Novo Nordisk 12.087, Amgen 8.618.

Novo Nordisk vs Amgen Net Worth and Market Cap

Novo Nordisk (NVO) and Amgen (AMGN) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $8.6B for Amgen. Novo Nordisk leads on revenue.

Novo Nordisk's gross margin is 78.2% versus 68.2% for Amgen. Novo Nordisk's net margin is 26.7% versus 21.1% for Amgen.

Key differences

  • Revenue growth on the same quarter a year earlier: Amgen +5.8% (Q1 2026), Novo Nordisk +2.1% (Q2 2026).
  • Novo Nordisk's KPIs on Sterling include Next-Generation Obesity: CagriSema + Amycretin Readouts and 2030 Ambitions (Capital Markets Day, 21 Sep 2026).
  • Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Amgen.
MetricNovo NordiskAmgen
Market Cap--
Revenue$12.09B$8.62B
Cost of Revenue$2.63B$2.74B
Gross Profit$9.45B$5.87B
Operating Income$4.17B$2.67B
Net Income$3.23B$1.82B
R&D Expense$2.74B$1.72B
Earnings Per Share$0.73$3.34
Gross Margin78.2%68.2%
Operating Margin34.5%30.9%
Net Profit Margin26.7%21.1%
Free Cash Flow$6.53B$1.48B
Cumulative Free Cash Flow$107.39B$165.69B
Operating Cash Flow$8.50B$2.19B
Cash & Equivalents$6.85B$12.04B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites